Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||
| Cash from operating activities | -3.64M | 2.25M | -7.42M | -590.49%-37.72M | -25.89M | -23.39%7.69M | 198.27%10.04M | 3.37M |
| Net profit before non-cash adjustment | --3.6M | --4.94M | --3.38M | -17.78%9.63M | --78.35K | 59.26%11.72M | 97.27%7.36M | --3.73M |
| Total adjustment of non-cash items | --3.28M | --2.55M | --2.66M | 28.94%8.46M | --2.59M | 20.81%6.56M | 17.24%5.43M | --4.63M |
| -Depreciation and amortization | --930K | --907K | --967K | 3.83%4.22M | --1.4M | 18.53%4.07M | 4.00%3.43M | --3.3M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | --5K | 161.01%363.81K | --645.81K | -235.64%-596.31K | 253.34%439.62K | --124.42K |
| -Disposal profit | ---- | ---- | ---- | -135.02%-23.5K | ---- | 95.82%-10K | 52.54%-239.1K | ---503.8K |
| -Other non-cash items | --2.1M | --1.65M | --1.69M | 25.68%3.9M | --561.14K | 72.29%3.1M | 5.07%1.8M | --1.71M |
| Changes in working capital | ---10.52M | ---5.24M | ---13.46M | -427.25%-55.82M | ---28.56M | -285.07%-10.59M | 44.98%-2.75M | ---5M |
| -Change in receivables | --553K | ---8.3M | --2.85M | -92.12%-41.45M | ---23.05M | -498.97%-21.57M | 346.55%5.41M | --1.21M |
| -Change in inventory | ---10.51M | --2.82M | --902K | -84.56%-21.6M | ---8.14M | 5.00%-11.71M | -1,024.49%-12.32M | ---1.1M |
| -Change in payables | ---561K | --238K | ---17.21M | -68.11%7.24M | --2.64M | 444.75%22.69M | 181.50%4.17M | ---5.11M |
| Dividends paid (cash flow from operating activities) | ||||||||
| Dividends received (cash flow from operating activities) | ||||||||
| Interest paid (cash flow from operating activities) | -2.24M | -1.67M | -1.73M | -25.49%-4.07M | -673.03K | -73.28%-3.24M | -5.05%-1.87M | -1.78M |
| Interest received (cash flow from operating activities) | 139K | 19K | 40K | 18.82%170.29K | 112.29K | 97.77%143.31K | 4.63%72.47K | 69.26K |
| Tax refund paid | -904K | -1.01M | -571K | -83.07%-4.55M | -2.1M | -113.40%-2.49M | -16.15%-1.17M | -1M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | ---6.64M | ---413K | ---9.68M | -2,296.72%-46.18M | ---28.55M | -70.28%2.1M | 990.19%7.07M | --648.78K |
| Investing cash flow | ||||||||
| Net PPE purchase and sale | ---167K | ---8.56M | ---1.61M | 51.89%-4.26M | ---2.25M | -354.56%-8.86M | -345.33%-1.95M | --794.07K |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | --2 | ---- | --1.23M |
| Investing cash flow | ---167K | ---8.56M | ---1.61M | 51.89%-4.26M | ---2.25M | -354.56%-8.86M | -196.48%-1.95M | --2.02M |
| Financing cash flow | ||||||||
| Net issuance payments of debt | --1.81M | --3.96M | --4.09M | 130.94%40.04M | --14.91M | 943.27%17.34M | 332.61%1.66M | ---714.4K |
| Net common stock issuance | ---- | ---- | ---- | --18.53M | ---- | --0 | ---- | ---- |
| Increase or decrease of lease financing | ---377K | ---267K | ---368K | 14.13%-1.19M | ---255.02K | 5.04%-1.38M | 38.17%-1.46M | ---2.36M |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---2M | ---- | ---- |
| Net other fund-raising expenses | ---1.53M | ---360K | ---806K | -86.13%-4.62M | ---617.55K | 28.89%-2.48M | -130.42%-3.49M | ---1.51M |
| Financing cash flow | ---101K | --3.33M | --2.92M | 359.95%52.76M | --32.57M | 449.16%11.47M | 28.38%-3.29M | ---4.59M |
| Net cash flow | ||||||||
| Beginning cash position | ---12.06M | ---6.42M | --1.95M | 92.77%-367.71K | --184K | 26.56%-5.09M | -38.34%-6.93M | ---5.01M |
| Current changes in cash | ---6.91M | ---5.64M | ---8.37M | -50.81%2.32M | --1.77M | 156.47%4.72M | 195.85%1.84M | ---1.92M |
| End cash Position | ---18.97M | ---12.06M | ---6.42M | 631.14%1.95M | --1.95M | 92.77%-367.71K | 26.56%-5.09M | ---6.93M |
| Free cash flow | ---6.81M | ---8.97M | ---11.29M | -646.16%-50.46M | ---30.82M | -238.42%-6.76M | 625.24%4.89M | ---930.19K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.